Expression of EphA2 and E-cadherin in Gastric Cancer: Correlated with Tumor Progression and Lymphogenous Metastasis

被引:41
|
作者
Yuan, Weijie [1 ]
Chen, Zhikang [1 ]
Wu, Shaobin [1 ]
Ge, Jie [1 ]
Chang, Shi [1 ]
Wang, Xianwei [1 ]
Chen, Jingxiang [1 ]
Chen, Zihua [1 ]
机构
[1] Cent S Univ, Dept Gen Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
关键词
EphA2; E-cadherin; Gastric cancer; Immunohistochemistry; RECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; CARCINOMA; OVEREXPRESSION; GENE; PHOSPHATASE; SURVIVAL; ADHESION; INVASION; FEATURES;
D O I
10.1007/s12253-008-9132-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, gastric cancer progression was correlated with the over-expression of erythropoietin-producing hepatocellular (Eph)A2 receptor and down-expression of epithelial cadherin (E-cadherin). Immunohistochemistry of EphA2 and E-cadherin were performed on these tumor samples from 165 primary lesions of gastric cancer. The results showed that expression of EphA2 was obviously increased in gastric cancer tissues (P<0.01), which was positively correlated with the depth of cancer invasion, tumor-node-metastasis (TNM) stage and lymph node metastasis (P<0.05). Meanwhile, the expression of E-cadherin was significantly reduced (P<0.01), which was negatively correlated with the depth of cancer invasion, grade of tumor differentiation, TNM stage and lymph node metas tasis (P<0.05). The correlation between EphA2 and E-cadherin expression was negative (r=-0.198, P=0.011). In conclusion, either the over-expression of EphA2 or the down-expression of E-cadherin is correlated with cancer progression and lymphogenous metastasis in gastric cancer, suggesting that both of them may play an important role in tumor progression and metastasis.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 50 条
  • [1] Expression of EphA2 and E-cadherin in colorectal cancer: Correlation with cancer metastasis
    Saito, T
    Masuda, N
    Miyazaki, T
    Kanoh, K
    Suzuki, H
    Shimura, T
    Asao, T
    Kuwano, H
    ONCOLOGY REPORTS, 2004, 11 (03) : 605 - 611
  • [2] E-cadherin regulates the function of the EphA2 receptor tyrosine kinase
    Zantek, ND
    Azimi, M
    Fedor-Chaiken, M
    Wang, BC
    Brackenbury, R
    Kinch, MS
    CELL GROWTH & DIFFERENTIATION, 1999, 10 (09): : 629 - 638
  • [3] E-cadherin, α- and β-catenins in gastric cancer expression
    Kim, OJ
    Stemmermann, G
    DeVoe, G
    Noffsinger, A
    MacDonald, J
    Fenoglio-Preiser, C
    LABORATORY INVESTIGATION, 2001, 81 (01) : 88A - 88A
  • [4] E-cadherin, α- and β-catenins in gastric cancer expression
    Kim, OJ
    Stemmermann, G
    DeVoe, G
    Noffsinger, A
    MacDonald, J
    Fenoglio-Preiser, C
    MODERN PATHOLOGY, 2001, 14 (01) : 88A - 88A
  • [5] Gastric cancer: Expression of E-cadherin in the primary tumor and sentinel lymph node
    Baykov, V.
    Alexeyev, D.
    VIRCHOWS ARCHIV, 2014, 465 : S146 - S147
  • [6] Loss of E-cadherin expression contribute to pancreatic tumor progression
    Kaneta, Yoshihiro
    Sugimori, Makoto
    Kanno, Masatomo
    Sato, Takeshi
    Sue, Soichiro
    Shibata, Wataru
    Maeda, Shin
    CANCER SCIENCE, 2018, 109 : 1040 - 1040
  • [7] Loss of E-cadherin expression in early gastric cancer
    Blok, P
    Craanen, ME
    Dekker, W
    Tytgat, GNJ
    HISTOPATHOLOGY, 1999, 34 (05) : 410 - 415
  • [8] Expression of E-cadherin and catenins in early gastric cancer
    Joo, YE
    Rew, JS
    Choi, SK
    Bom, HS
    Park, CS
    Kim, SJ
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (01) : 35 - 42
  • [9] E-cadherin in gastric cancer
    Annie On On Chan
    World Journal of Gastroenterology, 2006, (02) : 199 - 203
  • [10] EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
    Linfeng Mao
    Weijie Yuan
    Kaimei Cai
    Chen Lai
    Changhao Huang
    Yi Xu
    Shangwei Zhong
    Chen Yang
    Ran Wang
    Pengwei Zeng
    Heyuan Huang
    Zhikang Chen
    Zihua Chen
    Oncogene, 2021, 40 : 3610 - 3623